James Spencer
Orcid: 0000-0002-4602-0571
According to our database1,
James Spencer
authored at least 14 papers
between 2000 and 2024.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2024
Ligand-Based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against <i>Mycobacterium tuberculosis</i> and Hit Validation by Biological Assays.
J. Chem. Inf. Model., 2024
2023
Enhancement by pyrazolones of colistin efficacy against mcr-1-expressing E. coli: an in silico and in vitro investigation.
J. Comput. Aided Mol. Des., October, 2023
Bioisosteric Design Identifies Inhibitors of <i>Mycobacterium tuberculosis</i> DNA Gyrase ATPase Activity.
J. Chem. Inf. Model., May, 2023
2022
Virtual Screening Identifies Novel and Potent Inhibitors of <i>Mycobacterium tuberculosis</i> PknB with Antibacterial Activity.
J. Chem. Inf. Model., 2022
Identification of Potent DNA Gyrase Inhibitors Active against <i>Mycobacterium tuberculosis</i>.
J. Chem. Inf. Model., 2022
2021
J. Chem. Inf. Model., 2021
Crystallography and QM/MM Simulations Identify Preferential Binding of Hydrolyzed Carbapenem and Penem Antibiotics to the L1 Metallo-β-Lactamase in the Imine Form.
J. Chem. Inf. Model., 2021
2020
Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography.
J. Chem. Inf. Model., 2020
2019
Simulations of Shikimate Dehydrogenase from Mycobacterium tuberculosis in Complex with 3-Dehydroshikimate and NADPH Suggest Strategies for MtbSDH Inhibition.
J. Chem. Inf. Model., 2019
An Efficient Computational Assay for β-Lactam Antibiotic Breakdown by Class A β-Lactamases.
J. Chem. Inf. Model., 2019
2018
2015
F1000Research, 2015
2012
Proceedings of the 1st International Workshop on Sentiment Discovery from Affective Data, 2012
2000
Proceedings of the Intelligent Problem Solving, 2000